These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 12034149

  • 21. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure.
    Isnard R, Pousset F, Trochu J, Chafirovskaïa O, Carayon A, Golmard J, Lechat P, Thomas D, Bouhour J, Komajda M.
    Am J Cardiol; 2000 Aug 15; 86(4):417-21. PubMed ID: 10946035
    [Abstract] [Full Text] [Related]

  • 22. Effect of continuous positive airway pressure on mitral regurgitant fraction and atrial natriuretic peptide in patients with heart failure.
    Tkacova R, Liu PP, Naughton MT, Bradley TD.
    J Am Coll Cardiol; 1997 Sep 15; 30(3):739-45. PubMed ID: 9283534
    [Abstract] [Full Text] [Related]

  • 23. In patients with severe systolic dysfunction, only brain natriuretic peptide is related to diastolic restrictive pattern.
    Catuzzo B, Ciancamerla F, Bobbio M, Longo M, Trevi GP.
    J Card Fail; 2003 Aug 15; 9(4):303-10. PubMed ID: 13680551
    [Abstract] [Full Text] [Related]

  • 24. Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation.
    Berglund H, Boukter S, Theodorsson E, Vallin H, Edhag O.
    Br Heart J; 1990 Jul 15; 64(1):9-13. PubMed ID: 2143916
    [Abstract] [Full Text] [Related]

  • 25. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
    Tsutamoto T, Wada A, Maeda K, Hisanaga T, Fukai D, Maeda Y, Ohnishi M, Mabuchi N, Kinoshita M.
    Am Heart J; 1997 Nov 15; 134(5 Pt 1):910-6. PubMed ID: 9398103
    [Abstract] [Full Text] [Related]

  • 26. Plasma norepinephrine and atrial natriuretic peptide in heart failure: influence of felodipine in the third Vasodilator Heart Failure Trial. V-HeFT III investigators.
    Smith RF, Germanson T, Judd D, Wong M, Ziesche S, Anand IS, Taylor WR, Cohn JN.
    J Card Fail; 2000 Jun 15; 6(2):97-107. PubMed ID: 10908083
    [Abstract] [Full Text] [Related]

  • 27. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT, White M, Yan AT, Yusuf S, Rouleau JL, Maggioni AP, Hall C, Latini R, Afzal R, Floras J, Masson S, McKelvie RS, Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Investigators.
    Am J Cardiol; 2005 Sep 01; 96(5):698-704. PubMed ID: 16125499
    [Abstract] [Full Text] [Related]

  • 28. Atrial natriuretic peptide ANP(1-98) and ANP(99-126) in patients with severe chronic congestive heart failure: relation to echocardiographic measurements. A subgroup analysis from the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
    Eriksson SV, Caidahl K, Hall C, Eneroth P, Kjekshus J, Offstad J, Swedberg K.
    J Card Fail; 1995 Mar 01; 1(2):109-16. PubMed ID: 9420640
    [Abstract] [Full Text] [Related]

  • 29. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation.
    Wozakowska-Kapłon B, Opolski G, Janion M.
    Kardiol Pol; 2003 Apr 01; 58(4):255-63. PubMed ID: 14517556
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure.
    Klinge R, Hystad M, Kjekshus J, Karlberg BE, Djøseland O, Aakvaag A, Hall C.
    Scand J Clin Lab Invest; 1998 Dec 01; 58(8):683-91. PubMed ID: 10088206
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Atrial natriuretic peptide level after cardioversion of chronic atrial fibrillation.
    Wozakowska-Kaplon B, Opolski G.
    Int J Cardiol; 2002 May 01; 83(2):159-65. PubMed ID: 12007688
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study.
    Rossi A, Enriquez-Sarano M, Burnett JC, Lerman A, Abel MD, Seward JB.
    J Am Coll Cardiol; 2000 Apr 01; 35(5):1256-62. PubMed ID: 10758968
    [Abstract] [Full Text] [Related]

  • 39. Impact of epicardial ablation of concomitant atrial fibrillation on atrial natriuretic peptide levels and atrial function in 6 months follow-up: does preoperative ANP level predict outcome of ablation?
    Pizon M, Friedel N, Pizon M, Freundt M, Weyand M, Feyrer R.
    J Cardiothorac Surg; 2013 Nov 28; 8():218. PubMed ID: 24286219
    [Abstract] [Full Text] [Related]

  • 40. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation.
    Engelmann MD, Niemann L, Kanstrup IL, Skagen K, Godtfredsen J.
    Int J Cardiol; 2005 Oct 20; 105(1):31-9. PubMed ID: 16207542
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.